Bad Blood of Theranos

Theranos, the biotech startup that once promised revolutionary blood test technologies to the world, came to an end after evidence of its fraud finally came to bear. Journalist John Carreyrou unravels the rise and downfall of the company, once valued at $9B, in his book Bad Blood: Secrets and Lies in a Silicon Valley Startup. This post summarises a few factors that enabled Theranos’ rise, and several red flags that warranted greater scrutiny from cautious investors (in hindsight). Continue Reading …

Think Fast, Talk Smart

Effective communication is almost always a critical for success in business. Matt Abrahams, organisational behaviour lecturer at Stanford Graduate School of Business, outlines several communication techniques and exercises to assist with presentations and public speaking. Continue Reading …